VITAMIN D DEFICIENCY - ISSUES AND RECOMMENDATIONS

Nguyen Ngoc Hong Phuc1,
1 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Vitamin D deficiency has become a common problem for many individuals not only in Australia, but it is also a worldwide health problem as it is accumulatively linked to a variety of diseases across all age groups and diverse biological and environmental determinants. In developed and developing countries, vitamin D deficiency situation is likely different due to social norm and behavioural determinants rather than the shortage of health service support. In the light of this paper, the situation of vitamin D deficiency in high-risk groups as well as certain reasons for the occurrent situation in devloped countries in which the paper explore and collect data from an example of Australia. 

Article Details

References

1. Basit S. (2013) "Vitamin D in health and disease: a literature review" Br J Biomed Sci. 70(4):161-72.
2. Bilinski K, Boyages S. (2013) "Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data." BMJ Open. 20:3(6).
3. Bilinski K, Talbot P. (2014) "Vitamin d supplementation in australia: implications for the development of supplementation guidelines." J Nutr Metab 2014:374208.
4. D. S, P. G. (2015) "Vitamin D deficiency: Is the pandemic for real? Indian Journal of Community Medicine." Oct-Dec 2015;40(4):3.
5. Gezmish O, Black MJ. (2013) "Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood." J Cardiovasc Transl Res 6(4):588-603.
6. Holick MF. (2017) "The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention." Rev Endocr Metab Disord 18(2):153-165.
7. Mozos I, Marginean O. (2015) “Links between vitamin D deficiency and cardiovascular disease.” BioMed Research International; 2015:12.
8. Ruwanpathirana T, Owen A et al (2015) “Can oral vitamin D prevent the cardiovascular diseases among migrants in Australia? Provider perspective using Markov modelling.” Clin Exp Pharmacol Physiol 42(6):596-601.